These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29463808)

  • 1. A novel heterogeneous network-based method for drug response prediction in cancer cell lines.
    Zhang F; Wang M; Xi J; Yang J; Li A
    Sci Rep; 2018 Feb; 8(1):3355. PubMed ID: 29463808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach for drug response prediction in cancer cell lines via network representation learning.
    Yang J; Li A; Li Y; Guo X; Wang M
    Bioinformatics; 2019 May; 35(9):1527-1535. PubMed ID: 30304378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitask learning improves prediction of cancer drug sensitivity.
    Yuan H; Paskov I; Paskov H; González AJ; Leslie CS
    Sci Rep; 2016 Aug; 6():31619. PubMed ID: 27550087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
    Emdadi A; Eslahchi C
    J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferences of drug responses in cancer cells from cancer genomic features and compound chemical and therapeutic properties.
    Wang Y; Fang J; Chen S
    Sci Rep; 2016 Sep; 6():32679. PubMed ID: 27645580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Response Prediction by Globally Capturing Drug and Cell Line Information in a Heterogeneous Network.
    Le DH; Pham VH
    J Mol Biol; 2018 Sep; 430(18 Pt A):2993-3004. PubMed ID: 29966608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.
    Wei D; Liu C; Zheng X; Li Y
    BMC Bioinformatics; 2019 Jan; 20(1):44. PubMed ID: 30670007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Cancer Prediction of Cell-Line Drug Sensitivity Using Network-Based Methods.
    Pouryahya M; Oh JH; Mathews JC; Belkhatir Z; Moosmüller C; Deasy JO; Tannenbaum AR
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Copula Based Approach for Design of Multivariate Random Forests for Drug Sensitivity Prediction.
    Haider S; Rahman R; Ghosh S; Pal R
    PLoS One; 2015; 10(12):e0144490. PubMed ID: 26658256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular within and between score for drug response prediction in cancer cell lines.
    Wang S; Li J
    Mol Omics; 2020 Feb; 16(1):31-38. PubMed ID: 31802092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Cancer Drug Response using a Recommender System.
    Suphavilai C; Bertrand D; Nagarajan N
    Bioinformatics; 2018 Nov; 34(22):3907-3914. PubMed ID: 29868820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
    Daher A; de Groot J
    Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal drug prediction from personal genomics profiles.
    Sheng J; Li F; Wong ST
    IEEE J Biomed Health Inform; 2015 Jul; 19(4):1264-70. PubMed ID: 25781964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined tissue-engineered/in silico signature tool patient stratification in lung cancer.
    Göttlich C; Kunz M; Zapp C; Nietzer SL; Walles H; Dandekar T; Dandekar G
    Mol Oncol; 2018 Aug; 12(8):1264-1285. PubMed ID: 29797762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Drug Screens Support Precision Medicine.
    Gray JW; Mills GB
    Cancer Discov; 2015 Nov; 5(11):1130-2. PubMed ID: 26526695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.
    Blom K; Nygren P; Larsson R; Andersson CR
    SLAS Technol; 2017 Jun; 22(3):306-314. PubMed ID: 28378608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.
    Xu Y; Dong Q; Li F; Xu Y; Hu C; Wang J; Shang D; Zheng X; Yang H; Zhang C; Shao M; Meng M; Xiong Z; Li X; Zhang Y
    J Transl Med; 2019 Aug; 17(1):255. PubMed ID: 31387579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.